<DOC>
	<DOCNO>NCT00003583</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Drugs amifostine may protect normal cell side effect chemotherapy radiation therapy . PURPOSE : Phase II trial study effectiveness amifostine prevent side effect patient receive chemotherapy radiation therapy limited-stage small cell lung cancer .</brief_summary>
	<brief_title>Amifostine Prevent Side Effects Patients Who Are Receiving Chemotherapy Radiation Therapy Limited-Stage Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate reduction toxicity combine amifostine cisplatin , etoposide , radiotherapy patient limited stage small cell lung cancer . II . Evaluate response rate combination patient . III . Evaluate overall survival patient treat regimen . OUTLINE : This multicenter study . Patients receive cisplatin IV day 1 etoposide IV daily day 1-3 . This course repeat every 3 week total 4 course . Patients also receive concurrent radiotherapy 5 day per week 5.5 week start first course chemotherapy . Patients receive amifostine IV 15 minute 15-30 minute prior dose chemotherapy day 1-3 . Patients follow 6 12 week , every 3 month 9 month , every 6 month 1 year , death . PROJECTED ACCRUAL : There 20 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm limited stage small cell lung cancer Primary tumor must evaluable radiographically PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 01 Life expectancy : At least 3 month Hematopoietic : WBC great 4,000/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin le 1.5 mg/dL SGOT SGPT less 2 time normal Renal : Creatinine le 1.5 mg/dL Other : No concurrent active infection No prior malignancy except squamous basal cell carcinoma skin carcinoma situ cervix Not pregnant nursing Effective contraception require fertile patient PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>limited stage small cell lung cancer</keyword>
	<keyword>drug/agent toxicity tissue/organ</keyword>
	<keyword>radiation toxicity</keyword>
</DOC>